This study describes and analyzes the innovation of policies and public services of the Village Government of Tanjung continued, Muaro Jambi Regency, especially in the development of BUMDes so that they can move the wheels of the community's economy. Public policy innovation is a necessity that must be done to overcome problems that exist in society. From the point of view of the study of public policy policies and public services, it can be seen that the Village Government of Tanjung continued has developed several BUMDes development strategies that have led this village to become a pilot village in Muaro Jambi Regency even though it had to face various obstacles. However, the concept of obstacles will give birth to a new concept in the policy process and public services. Abstrak: Penelitian ini mendeskripsikan serta menganalisis inovasi kebijakan dan pelayanan publik Pemerintah Desa Tanjung Lanjut Kabupaten Muaro Jambi khususnya dalam pengembangan BUMDes sehingga dapat menggerakkan roda perekonomian masyarakat. Inovasi kebijakan publik adalah sebuah keniscayaan yang harus dilakukan untuk mengatasi problematika yang hadir di tengah masyarakat. Dalam sudut pandang kajian kebijakan publik dan pelayanan publik dapat tergambar bahwa Pemerintah Desa Tanjung Lanjut telah mengembangkan beberapa strategi pengembangan BUMDes yang mengantarkan desa ini menjadi desa percontohan di Kabupaten Muaro Jambi meskipun harus menghadapi berbagai hambatan. Namun demikian pada dasarnya hambatan itu akan melahirkan sebuah konsep baru dalam proses kebijakan dan pelayanan publik.

… Background: Pneumonia is lower respiratory tract infection (LRTI) and represents inflammatory conditions of the lungs i.e of the lower respiratory tracts, air sacs and lung parenchyma. 1 Objectives: To determine the role of vitamin D supplementation in reducing morbidity in children with pneumonia. Study Design: Randomized Controlled trial. Place and Duration of Study: Pediatric Department, Mayo Hospital Lahore from December 2014 to May 2015. Patient & Methods: Two hundred children of age 2-59 months with pneumonia (fever, cough, tachypnea, and subcostal recessions) and low vitamin D level (< 20 ng/ml) were included in the study. One Hundred pneumonia patients received antibiotics (group A) and vitamins D (100,000 IU) while another group of hundred patients received only antibiotics without vitamin supplementation (group B). When respiratory distress settled, length of stay in hospital was calculated at the time of discharged. All patients were followed in pediatric OPDs for 3 months after in-hospital treatment to pick recurrence of pneumonia symptoms (if any). Results: The mean recovery time for vitamin D group (5.7 +2.8 days) and non-vitamin D (6.1+2.8 days) was almost same with P=0.29. But the frequency of repeated episodes of pneumonia within 30 days of treatment was lower in intervention group n=4 (2%) than the non-intervention group n=18 (9%) (P = 0.002). Conclusion: 100,000 IU of vitamin D given once during treatment of pneumonia decreases the chances of recurrence in the next 30 days.

Background: Pneumonia is lower respiratory tract infection (LRTI) andrepresents inflammatory conditions of the lungs i.e of the lower respiratory tracts, air sacs andlung parenchyma.1 Objectives: To determine the role of vitamin D supplementation in reducingmorbidity in children with pneumonia. Study Design: Randomized Controlled trial. Place andDuration of Study: Pediatric Department, Mayo Hospital Lahore from December 2014 to May2015. Patient & Methods: Two hundred children of age 2 – 59 months with pneumonia (fever,cough, tachypnea, and subcostal recessions) and low vitamin D level (< 20 ng/ml) were includedin the study. One Hundred pneumonia patients received antibiotics (group A) and vitamins D(100,000 IU) while another group of hundred patients received only antibiotics without vitaminsupplementation (group B). When respiratory distress settled, length of stay in hospital wascalculated at the time of discharged. All patients were followed in pediatric OPDs for 3 monthsafter in-hospital treatment to pick recurrence of pneumonia symptoms (if any). Results: Themean recovery time for vitamin D group (5.7 +2.8 days) and non-vitamin D (6.1+2.8 days)was almost same with P=0.29. But the frequency of repeated episodes of pneumonia within30 days of treatment was lower in intervention group n=4 (2%) than the non-intervention groupn=18 (9%) (P = 0.002). Conclusion: 100,000 IU of vitamin D given once during treatment ofpneumonia decreases the chances of recurrence in the next 30 days.